@scope (#mos-b9d7b32a-24d2-4e4c-9ff6-32ed31e9b2cd) { @font-face {
font-family: “Independent Serif”;
src: url(“https://assets.the-independent.com/fonts/Independent-Serif-Medium.woff2”) format(“woff2”);
font-weight: 500;
font-style: normal;
font-display: swap;
}
@font-face {
font-family: “Independent Serif”;
src: url(“https://assets.the-independent.com/fonts/Independent-Serif-Regular.woff2”) format(“woff2”);
font-weight: 400;
font-style: normal;
font-display: swap;
}
@font-face {
font-family: “Independent Sans”;
src: url(“https://assets.the-independent.com/fonts/Independent-Sans-Regular.woff2”) format(“woff2”);
font-weight: 400;
font-style: normal;
font-display: swap;
}
@font-face {
font-family: “Independent Sans”;
src: url(“https://assets.the-independent.com/fonts/Independent-Sans-Medium.woff2”) format(“woff2”);
font-weight: 500;
font-style: normal;
font-display: swap;
}
.bookmark-experience {
box-sizing: border-box;
display: flex;
align-items: center;
justify-content: center;
position: fixed;
top: 0;
left: 0;
right: 0;
bottom: 0;
inset: 0;
width: 100%;
height: 100%;
background-color: rgba(0, 0, 0, 0.55);
z-index: 10000;
padding: 12px;
margin: 0;
}
.bookmark-experience,
.bookmark-experience * {
box-sizing: border-box;
}
.bookmark-experience .modal {
position: relative;
width: 100%;
max-width: 400px;
margin: 0;
padding: 32px 24px 28px;
text-align: center;
color: #ffffff;
background: linear-gradient(90deg, #3b030f 0%, #3b030f 27%, #76071f 52%, #3b030f 100%);
box-shadow: 2px -2px 8px rgba(0, 0, 0, 0.5);
}
.bookmark-experience .close-btn {
position: absolute;
top: 12px;
right: 12px;
width: 16px;
height: 16px;
cursor: pointer;
background: none;
border: none;
padding: 0;
}
.bookmark-experience .close-btn__icon,
.bookmark-experience .close-btn__icon::before,
.bookmark-experience .close-btn__icon::after {
display: block;
}
.bookmark-experience .close-btn__icon {
position: relative;
width: 16px;
height: 16px;
}
.bookmark-experience .close-btn__icon::before,
.bookmark-experience .close-btn__icon::after {
content: “”;
position: absolute;
top: 50%;
left: 0;
width: 16px;
height: 1.5px;
background: #ffffff;
}
.bookmark-experience .close-btn__icon::before { transform: translateY(-50%) rotate(45deg); }
.bookmark-experience .close-btn__icon::after { transform: translateY(-50%) rotate(-45deg); }
.bookmark-experience .logo-row {
display: flex;
align-items: center;
justify-content: center;
margin: 0 0 24px;
}
.bookmark-experience .logo-premium-image {
display: block;
height: 24px;
width: 272px;
max-width: 86%;
object-fit: contain;
}
.bookmark-experience .headline {
font-family: “Independent Serif”, Georgia, serif;
font-weight: 500;
font-size: 28px;
line-height: 32px;
letter-spacing: -0.5px;
color: #ffffff;
margin: 0 0 16px;
}
.bookmark-experience .body-text {
font-family: “Independent Serif”, Georgia, serif;
font-weight: 400;
font-size: 16px;
line-height: 22px;
letter-spacing: -0.3px;
color: #ffffff;
margin: 0 0 24px;
}
.bookmark-experience .subscribe-link {
display: flex;
align-items: center;
justify-content: center;
width: 100%;
height: 42px;
padding: 12px 16px;
background: #ffffff;
color: #76071f;
border-radius: 4px;
font-family: “Independent Sans”, -apple-system, BlinkMacSystemFont, “Segoe UI”, Roboto, sans-serif;
font-size: 14px;
font-weight: 500;
line-height: 16px;
letter-spacing: -0.5px;
text-transform: uppercase;
text-decoration: none;
}
.bookmark-experience .subscribe-link:hover,
.bookmark-experience .subscribe-link:focus {
background: #f0e6e8;
color: #76071f;
}
.bookmark-experience .login-copy {
margin: 12px 0 0;
font-family: “Independent Sans”, -apple-system, BlinkMacSystemFont, “Segoe UI”, Roboto, sans-serif;
font-size: 14px;
line-height: 18px;
letter-spacing: -0.5px;
color: #ffffff;
}
.bookmark-experience .login-link {
color: #ffffff;
text-decoration: underline;
cursor: pointer;
}
@media screen and (min-width: 600px) {
.bookmark-experience {
padding: 16px;
}
.bookmark-experience .modal {
max-width: 520px;
padding: 40px 48px 32px;
}
.bookmark-experience .close-btn,
.bookmark-experience .close-btn__icon,
.bookmark-experience .close-btn__icon::before,
.bookmark-experience .close-btn__icon::after {
width: 16px;
}
.bookmark-experience .close-btn {
top: 16px;
right: 16px;
}
.bookmark-experience .logo-premium-image {
height: 28px;
width: 320px;
}
.bookmark-experience .headline {
font-size: 32px;
line-height: 36px;
letter-spacing: -0.75px;
margin-bottom: 16px;
}
.bookmark-experience .body-text {
font-size: 16px;
line-height: 22px;
margin-bottom: 28px;
}
}
}
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.
Already a member?
Log in
html:not(.mos-bookmark-open) .bookmark-experience { display: none !important; }
One of the world’s top marathon runners has been given a six-year ban from the sport after submitting a fake prescription to attempt to explain a positive drug test.
Ruti Aga, who won the Tokyo Marathon in 2019, returned a positive test for the banned substance methylprednisolone, a steroid which is used to reduce pain, after winning a half-marathon in China in March.
The Ethiopian claimed she had been prescribed the drug to treat a knee injury which she had been suffering from since April 2015.
But an investigation into her test by the Ethiopian Anti-Doping Authority revealed that the prescription she submitted came from a medical clinic which did not actually exist, and was issued to her by a family member who had “no medical registration with the relevant authority”.
Aga was charged with violating three anti-doping regulations but did not respond to the charges before the deadline, which could potentially have taken a year off her suspension if she admitted the breaches. The ban was therefore issued without a hearing.
The Athletics Integrity Unit (AIU) said on Thursday that it had banned Aga for two years for the positive test and a further four years, to be served consecutively, for “tampering” with the investigation.
Aga attempted “to mislead the investigation by providing false information in an interview” in April and produced a “forged/manipulated document” in May, according to the AIU’s press release on the case.
The 32-year-old was ranked 11th in the world at the time of testing positive and as well as claiming the Tokyo title in 2019 had four top-three finishes at World Marathon Majors.
The AIU’s chief executive, Brett Clothier, said: “Protecting clean competition takes resources, but this case sends a clear message: attempts to cheat will be exposed”.
